Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 1;28(6):1230-1242.
doi: 10.1093/annonc/mdx054.

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

Affiliations
Review

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

S Stacchiotti et al. Ann Oncol. .

Abstract

Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.

Keywords: chemotherapy; chordoma; radiotherapy; relapse; sarcoma; surgery.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow-charts summarizing the recommended treatment strategy for patients with local-regional recurrence. MR, magnetic resonance; CT, computerized tomography; prog., progressioni; WB, whole body; REF, reference; RT, radiotherapy.

Similar articles

  • Building a global consensus approach to chordoma: a position paper from the medical and patient community.
    Stacchiotti S, Sommer J; Chordoma Global Consensus Group. Stacchiotti S, et al. Lancet Oncol. 2015 Feb;16(2):e71-83. doi: 10.1016/S1470-2045(14)71190-8. Lancet Oncol. 2015. PMID: 25638683
  • Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
    Freeman JL, Kaufmann AB, Everson RG, DeMonte F, Raza SM. Freeman JL, et al. Oper Neurosurg. 2019 Jan 1;16(1):27-36. doi: 10.1093/ons/opy073. Oper Neurosurg. 2019. PMID: 29912434
  • Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
    Stacchiotti S, Miah AB, Frezza AM, Messiou C, Morosi C, Caraceni A, Antonescu CR, Bajpai J, Baldini E, Bauer S, Biagini R, Bielack S, Blay JY, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Callegaro D, De Alava E, Deoras-Sutliff M, Dufresne A, Eriksson M, Errani C, Fedenko A, Ferraresi V, Ferrari A, Fletcher CDM, Garcia Del Muro X, Gelderblom H, Gladdy RA, Gouin F, Grignani G, Gutkovich J, Haas R, Hindi N, Hohenberger P, Huang P, Joensuu H, Jones RL, Jungels C, Kasper B, Kawai A, Le Cesne A, Le Grange F, Leithner A, Leonard H, Lopez Pousa A, Martin Broto J, Merimsky O, Merriam P, Miceli R, Mir O, Molinari M, Montemurro M, Oldani G, Palmerini E, Pantaleo MA, Patel S, Piperno-Neumann S, Raut CP, Ravi V, Razak ARA, Reichardt P, Rubin BP, Rutkowski P, Safwat AA, Sangalli C, Sapisochin G, Sbaraglia M, Scheipl S, Schöffski P, Strauss D, Strauss SJ, Sundby Hall K, Tap WD, Trama A, Tweddle A, van der Graaf WTA, Van De Sande MAJ, Van Houdt W, van Oortmerssen G, Wagner AJ, Wartenberg M, Wood J, Zaffaroni N, Zimmermann C, Casali PG, Dei Tos AP, Gronchi A. Stacchiotti S, et al. ESMO Open. 2021 Jun;6(3):100170. doi: 10.1016/j.esmoop.2021.100170. Epub 2021 Jun 2. ESMO Open. 2021. PMID: 34090171 Free PMC article. Review.
  • Chordoma: the nonsarcoma primary bone tumor.
    Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH. Chugh R, et al. Oncologist. 2007 Nov;12(11):1344-50. doi: 10.1634/theoncologist.12-11-1344. Oncologist. 2007. PMID: 18055855 Review.
  • Contemporary management of clival chordomas.
    Campbell RG, Prevedello DM, Ditzel Filho L, Otto BA, Carrau RL. Campbell RG, et al. Curr Opin Otolaryngol Head Neck Surg. 2015 Apr;23(2):153-61. doi: 10.1097/MOO.0000000000000140. Curr Opin Otolaryngol Head Neck Surg. 2015. PMID: 25692630 Review.

Cited by

References

    1. Flanagan AM, Yamaguchi T, Chordoma In Fletcher CDM, Bridge JA, Pancras CW, Mertens F (eds), World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics. Lyon: IARC Press; 2013; 328–329.
    1. Stacchiotti S, Sommer J. on behalf of a Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol 2015; 16: 71–83. - PubMed
    1. Weber DC, Malyapa R, Albertini F. et al. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol 2016; 120: 169–174. - PubMed
    1. Tzortzidis F, Elahi F, Wright D. et al. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 2006; 59: 230–237. - PubMed
    1. Cloyd JM, Acosta FL Jr, Polley MY. et al. En bloc resection for primary and metastatic tumors of the spine: a systematic review of the literature. Neurosurgery 2010; 67: 435–444. - PubMed